Evidence map›Paper›PMID 25267199›Full record

ArticleBlood2014

OVOL2 is a critical regulator of ER71/ETV2 in generating FLK1+, hematopoietic, and endothelial cells from embryonic stem cells.

Ju Young Kim, Ra Ham Lee, Tae Min Kim, Dong-Wook Kim, Young-Joo Jeon, Sung-Ho Huh, Se-Yeong Oh, Michael Kyba, Hiroshi Kataoka, Kyunghee Choi and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Endothelial cell direct reprogramming: Past, present, and future.Journal of molecular and cellular cardiology · 2023
    Review
  7. Review
  8. Article
  9. Article
  10. ETV2/ER71 regulates the generation of FLK1Stem cell research & therapy · 2019
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Ju Young KimDepartment of Pediatrics, Center for Cardiovascular Biology, Emory University School of Medicine, Atlanta, GA; Department of Pharmacology, College of Medicine, University of Illinois, Chicago, IL;
Ra Ham LeeDepartment of Oral Pharmacology, School of Dentistry, Chonbuk National University, Jeonju, Republic of Korea;
Tae Min KimDepartment of Pharmacology, College of Medicine, University of Illinois, Chicago, IL;
Dong-Wook KimDepartment of Oral Pharmacology, School of Dentistry, Chonbuk National University, Jeonju, Republic of Korea;
Young-Joo JeonDepartment of Oral Pharmacology, School of Dentistry, Chonbuk National University, Jeonju, Republic of Korea;
Sung-Ho HuhDepartment of Developmental Biology, Washington University School of Medicine, St. Louis, MO;
Se-Yeong OhDepartment of Pediatrics, Center for Cardiovascular Biology, Emory University School of Medicine, Atlanta, GA;
Michael KybaDepartment of Medicine, Medical School, University of Minnesota, Minneapolis, MN;
Hiroshi KataokaLaboratory for Stem Cell Biology, RIKEN Center for Developmental Biology, Chuo-ku, Kobe, Japan; and.
Kyunghee ChoiDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.
David M OrnitzDepartment of Developmental Biology, Washington University School of Medicine, St. Louis, MO;
Jung-Il ChaeDepartment of Oral Pharmacology, School of Dentistry, Chonbuk National University, Jeonju, Republic of Korea;
Changwon ParkDepartment of Pediatrics, Center for Cardiovascular Biology, Emory University School of Medicine, Atlanta, GA; Department of Pharmacology, College of Medicine, University of Illinois, Chicago, IL;
Jeonbuk National University · KREmory University · USWashington University in St. Louis · USUniversity of Illinois Chicago · USUniversity of Minnesota Medical Center · US

Funding

HEMATOPOIETIC COMMITMENT: MOLECULAR MECHANISMSR01HL063736 · NHLBI · WASHINGTON UNIVERSITY · PI CHOI, KYUNGHEE · 2000 to 2016
$5.6M
Mechanisms of ER71/ETV2-regulated VascularizationR01HL119291 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PARK, CHANGWON · 2013 to 2022
$3.2M
FIBROBLAST GROWTH FACTOR SIGNALING IN HEART INJURY AND REPAIRR01HL105732 · NHLBI · WASHINGTON UNIVERSITY · PI ORNITZ, DAVID M · 2011 to 2015
$1.9M
NHLBI NIH HHS HL105732NHLBI NIH HHS HL119291NHLBI NIH HHS R01 HL063736NHLBI NIH HHS R01 HL105732NHLBI NIH HHS R01 HL119291
6 · The paper itself

Abstract

In this study, we report that OVOL2, a C2H2 zinc finger protein, is a novel binding protein of ER71, which is a critical transcription factor for blood and vessel development. OVOL2 directly interacted with ER71, but not with ETS1 or ETS2, in the nucleus. ER71-mediated activation of the Flk1 promoter was further enhanced by OVOL2, although OVOL2 alone failed to activate it. Consistently, coexpression of ER71 and OVOL2 in differentiating embryonic stem cells led to a significant augmentation of FLK1(+), endothelial, and hematopoietic cells. Such cooperative effects were impaired by the short hairpin RNA-mediated inhibition of Ovol2. Collectively, we show that ER71 directly interacts with OVOL2 and that such interaction is critical for FLK1(+) cell generation and their differentiation into downstream cell lineages.

Indexed as

AnimalsCell LineageCells, CulturedEmbryonic Stem CellsEndothelial CellsGene Knockdown TechniquesHematopoietic Stem CellsMiceProteomicsRNA, Small InterferingSignal TransductionTranscription FactorsVascular Endothelial Growth Factor Receptor-2ER71 protein, mouseKdr protein, mouseMOVO protein, mouseRNA, Small InterferingTranscription FactorsVascular Endothelial Growth Factor Receptor-2

Identifiers

PMID25267199
PMCPMC4224193
OpenAlexW2043167948

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.